In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...
All content for Stem Cell Genius is the property of David Greene and Samantha Brechner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...
In this episode, Samantha sits down with Dr. Greene to ask your most pressing questions about autism and stem cell therapy. We dive into who is a candidate, explore where and how we treat ASD at R3, and cover so much more about this groundbreaking approach to autism care. Get ready for an insightful conversation that could change how you think about autism treatment options. Call +1(844) GET-STEM to see if you or a loved one is a candidate.
Stem Cell Genius
In this episode of Stem Cell Genius, Samantha Brechner, President of R3 Stem Cell, sits down with the visionary Founder and CEO of R3 Stem Cell, Dr. David Greene, to explore one of the most important questions in regenerative medicine — How do stem cells differ in the United States compared to international use? Together, they dive into the contrasts in regulations, sources, and applications of stem cells across borders. From the highly regulated environment in the U.S. to the broader, less r...
